Table 1 Medications for treatment of generalized anxiety disorder
Medication Type | Comment |
|---|---|
Benzodiazepines | |
Short-acting | |
Alprazolam | >2 mg/d deemed potentially inappropriate |
Bromazepam | |
Lorazepam | >3 mg/d deemed potentially inappropriate |
Lormetazepam | |
Nitrazepam | |
Oxazepam | >60 mg/d deemed potentially inappropriate |
Temazepam | >15 mg/d deemed potentially inappropriate |
Tetrazepam | |
Triazolam | >0.25 mg/d deemed potentially inappropriate |
Zolpidem | >5 mg/d deemed potentially inappropriate |
Long-acting | |
Chlordiazepoxide | All long-acting benzodiazepines deemed potentially inappropriate |
Chlorazepate | All long-acting benzodiazepines deemed potentially inappropriate |
Clobazam | All long-acting benzodiazepines deemed potentially inappropriate |
Clonazepam | All long-acting benzodiazepines deemed potentially inappropriate |
Diazepam | All long-acting benzodiazepines deemed potentially inappropriate |
Flunitrazepam | All long-acting benzodiazepines deemed potentially inappropriate |
Flurazepam | All long-acting benzodiazepines deemed potentially inappropriate |
Halazepam | All long-acting benzodiazepines deemed potentially inappropriate |
Medazepam | All long-acting benzodiazepines deemed potentially inappropriate |
Nordazepam | All long-acting benzodiazepines deemed potentially inappropriate |
Prezepam | All long-acting benzodiazepines deemed potentially inappropriate |
Tricyclic antidepressants | |
Amitriptyline | Deemed potentially inappropriate |
Amitriptylinoxide | |
Clomipramine | |
Dibenzepin | |
Desipramine | |
Doxepin | Deemed potentially inappropriate |
Imipramine | |
Maprotiline | |
Nortiptyline | |
Opipramol | |
Trimipramine | |
Selective serotonin reuptake inhibitor | |
Escitalopram | |
Citalopram | |
Fluoxetine | |
Fluvoxamine | |
Paroxetine | |
Sertraline | |
Venlafaxine | |
Hydroxyzine | Deemed potentially inappropriate |
Buspirone | |
Pregabalin | |
Trifluoperazine |